230 related articles for article (PubMed ID: 38022579)
1. Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers.
Phat NK; Tien NTN; Anh NK; Yen NTH; Lee YA; Trinh HKT; Le KM; Ahn S; Cho YS; Park S; Kim DH; Long NP; Shin JG
Front Immunol; 2023; 14():1210372. PubMed ID: 38022579
[TBL] [Abstract][Full Text] [Related]
2. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring.
Bayaa R; Ndiaye MDB; Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Nasrin R; Ranaivomanana P; Raherinandrasana AH; Rakotonirina J; Rasolofo V; Delogu G; De Maio F; Goletti D; Endtz H; Ader F; Hamze M; Ismail MB; Pouzol S; Rakotosamimanana N; Hoffmann J;
Sci Rep; 2021 Jul; 11(1):13646. PubMed ID: 34211042
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis.
Long NP; Anh NK; Yen NTH; Phat NK; Park S; Thu VTA; Cho YS; Shin JG; Oh JY; Kim DH
Sci Rep; 2022 Aug; 12(1):13395. PubMed ID: 35927287
[TBL] [Abstract][Full Text] [Related]
4. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Penn-Nicholson A; Mbandi SK; Thompson E; Mendelsohn SC; Suliman S; Chegou NN; Malherbe ST; Darboe F; Erasmus M; Hanekom WA; Bilek N; Fisher M; Kaufmann SHE; Winter J; Murphy M; Wood R; Morrow C; Van Rhijn I; Moody B; Murray M; Andrade BB; Sterling TR; Sutherland J; Naidoo K; Padayatchi N; Walzl G; Hatherill M; Zak D; Scriba TJ; ; ; ; ; ; ; ;
Sci Rep; 2020 May; 10(1):8629. PubMed ID: 32451443
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
Gebremicael G; Kassa D; Alemayehu Y; Gebreegziaxier A; Kassahun Y; van Baarle D; H M Ottenhoff T; M Cliff J; C Haks M
PLoS One; 2019; 14(12):e0226137. PubMed ID: 31821366
[TBL] [Abstract][Full Text] [Related]
6. Utility of a three-gene transcriptomic signature in the diagnosis of tuberculosis in a low-endemic hospital setting.
Chendi BH; Jooste T; Scriba TJ; Kidd M; Mendelsohn S; Tonby K; Walzl G; Dyrhol-Riise AM; Chegou NN
Infect Dis (Lond); 2023 Jan; 55(1):44-54. PubMed ID: 36214761
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as immune regulators and biomarkers in tuberculosis.
Wang L; Xiong Y; Fu B; Guo D; Zaky MY; Lin X; Wu H
Front Immunol; 2022; 13():1027472. PubMed ID: 36389769
[TBL] [Abstract][Full Text] [Related]
8. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis.
Qian Z; Lv J; Kelly GT; Wang H; Zhang X; Gu W; Yin X; Wang T; Zhou T
Tuberculosis (Edinb); 2016 Jul; 99():56-62. PubMed ID: 27450006
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.
Kaipilyawar V; Zhao Y; Wang X; Joseph NM; Knudsen S; Prakash Babu S; Muthaiah M; Hochberg NS; Sarkar S; Horsburgh CR; Ellner JJ; Johnson WE; Salgame P
Clin Infect Dis; 2022 Sep; 75(6):1022-1030. PubMed ID: 35015839
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Biomarkers for Tuberculosis: Validation of
de Araujo LS; Ribeiro-Alves M; Wipperman MF; Vorkas CK; Pessler F; Saad MHF
Cells; 2021 Oct; 10(10):. PubMed ID: 34685683
[TBL] [Abstract][Full Text] [Related]
11. Classification and characterisation of extracellular vesicles-related tuberculosis subgroups and immune cell profiles.
Zhou P; Shen J; Ge X; Ding F; Zhang H; Huang X; Zhao C; Li M; Li Z
J Cell Mol Med; 2023 Sep; 27(17):2482-2494. PubMed ID: 37409682
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.
Lee SW; Wu LS; Huang GM; Huang KY; Lee TY; Weng JT
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818387
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
Natarajan S; Ranganathan M; Hanna LE; Tripathy S
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
[TBL] [Abstract][Full Text] [Related]
14. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
15. Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol.
Mulenga H; Bunyasi EW; Mbandi SK; Mendelsohn SC; Kagina B; Penn-Nicholson A; Scriba T; Hatherill M
BMJ Open; 2019 May; 9(5):e026612. PubMed ID: 31122978
[TBL] [Abstract][Full Text] [Related]
16. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
Porter BW; Venkatappa TK
Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
[TBL] [Abstract][Full Text] [Related]
17. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis.
Roe JK; Thomas N; Gil E; Best K; Tsaliki E; Morris-Jones S; Stafford S; Simpson N; Witt KD; Chain B; Miller RF; Martineau A; Noursadeghi M
JCI Insight; 2016 Oct; 1(16):e87238. PubMed ID: 27734027
[No Abstract] [Full Text] [Related]
18. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.
Kaforou M; Wright VJ; Oni T; French N; Anderson ST; Bangani N; Banwell CM; Brent AJ; Crampin AC; Dockrell HM; Eley B; Heyderman RS; Hibberd ML; Kern F; Langford PR; Ling L; Mendelson M; Ottenhoff TH; Zgambo F; Wilkinson RJ; Coin LJ; Levin M
PLoS Med; 2013 Oct; 10(10):e1001538. PubMed ID: 24167453
[TBL] [Abstract][Full Text] [Related]
19. The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.
Blankley S; Graham CM; Turner J; Berry MP; Bloom CI; Xu Z; Pascual V; Banchereau J; Chaussabel D; Breen R; Santis G; Blankenship DM; Lipman M; O'Garra A
PLoS One; 2016; 11(10):e0162220. PubMed ID: 27706152
[TBL] [Abstract][Full Text] [Related]
20. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson A; Hraha T; Thompson EG; Sterling D; Mbandi SK; Wall KM; Fisher M; Suliman S; Shankar S; Hanekom WA; Janjic N; Hatherill M; Kaufmann SHE; Sutherland J; Walzl G; De Groote MA; Ochsner U; Zak DE; Scriba TJ;
PLoS Med; 2019 Apr; 16(4):e1002781. PubMed ID: 30990820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
